Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine

Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures

Bruno C. Hancock, Sheri L. Shamblin, George Zografi · Pharmaceutical Research · 1995 · 883 citations

Natural Sciences, Chemistry, Materials Science +15

Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings

Daniel B. Jernigan, Pratima L. Raghunathan, Beth P. Bell et al. · Emerging infectious diseases · 2002 · 705 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Is trehalose special for preserving dry biomaterials?

Lois M. Crowe, David S. Reid, J.H. Crowe · Biophysical Journal · 1996 · 590 citations · Full text

Natural Sciences, Biochemistry, Biotechnology +10

Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

Frederik W. van Ginkel, Raymond J. Jackson, Yoshikazu Yuki et al. · The Journal of Immunology · 2000 · 365 citations

Life Sciences, Immunology, Mucosal Immunology +16

COMPOUND 48/80: A POTENT HISTAMINE LIBERATOR

W. D. M. Paton · British Journal of Pharmacology and Chemotherapy · 1951 · 349 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8